Dave Pagliarini, lead investigator of metabolism for the Morgridge Institute for Research and associate professor of biochemistry at the University of Wisconsin-Madison, is being recognized for major early-career achievement by The Protein Society.
From Rosalind Franklin to Edwin Hubble, history has shown that athleticism and scientific prowess are not mutually exclusive traits.
In order to understand the biochemical underpinnings of disease, it is imperative to shrink down to the molecular level. It’s this mentality that steered Mateusz Manicki all the way from Poland’s Gdansk University to Madison, Wisconsin to study mitochondrial proteins. Manicki will be using mass spectrometry resources to better understand the functionality of cells contributing to a given disease.
The Laboratory of Biomolecular Mass Spectrometry (LBMS), launched in summer 2015, accelerates the university’s ability to apply this powerful technology to high-impact projects, says Joshua Coon, UW-Madison professor of chemistry and biomolecular chemistry and LBMS director.
Can we fight cancer by targeting its metabolism, essentially starving tumors of the nutrients they need to survive? It’s one of the intriguing big-picture questions in the research field of Jing Fan, a new investigator in the Morgridge Institute for Research metabolism theme.